Clinical Trials · NCT03199261
A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Enrollment
- 24
- Start date
- Dec 2016
- Locations
- 1 site, China
- Primary endpoint
- Bioequivalency between the 2 formulations of rE-4